44 related articles for article (PubMed ID: 11429214)
1. Intensity of cervical inflammatory reaction as a risk factor for recurrence of carcinoma of the uterine cervix in stages IB and IIA.
Fregnani JH; Soares FA; Novik PR; Lopes A; Latorre Mdo R
Sao Paulo Med J; 2007 Jul; 125(4):231-6. PubMed ID: 17992395
[TBL] [Abstract][Full Text] [Related]
2. Long-term clinical outcomes of preoperative brachytherapy in early-stage cervical cancer.
Buchalet C; Loap P; Losa S; Laas E; Gaillard T; Lecuru F; Malhaire C; Huchet V; De La Rochefordiere A; Labib A; Kissel M
Eur J Surg Oncol; 2024 Jun; 50(6):108342. PubMed ID: 38636247
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of prognostic factors for cancer of the uterine cervix after radical hysterectomy.
Tavares MB; Sousa RB; Oliveira e Silva T; Moreira LA; Silva LT; Tavares CB; Vieira SC
Sao Paulo Med J; 2009; 127(3):145-9. PubMed ID: 19820876
[TBL] [Abstract][Full Text] [Related]
4. Brachytherapy and surgery versus surgery alone for IB2 (FIGO 2018) cervical cancers: A FRANCOGYN study.
Aissaoui O; Phalippou J; Cordoba A; Azais H; Ouldamer L; Bolze PA; Ballester M; Huchon C; Mimoun C; Akladios C; Lecointre L; Raimond E; Graesslin O; Carcopino X; Lavoué V; Bendifallah S; Touboul C; Dabi Y; Canlorbe G; Koskas M; Chauvet P; Collinet P; Kerbage Y
Eur J Obstet Gynecol Reprod Biol; 2023 Nov; 290():128-134. PubMed ID: 37788511
[TBL] [Abstract][Full Text] [Related]
5. Pelvic lymph node involvement and risk of recurrence in HPV-associated endocervical adenocarcinoma stage IA2-IB1 according to Silva's system in two Colombian cancer centers.
Hernández JA; Rodríguez J; Rendón G; Trujillo LM; Beltrán MI; Mantilla C; Echeverry C; Mendoza MA; Gil M; Núñez M; Hernández M; Peralta J; Pareja R
Int J Gynaecol Obstet; 2024 Mar; ():. PubMed ID: 38546455
[TBL] [Abstract][Full Text] [Related]
6. Pre-operative high-dose-rate brachytherapy in early-stage cervical cancer: long-term single-center results.
Kellas-Ślęczka S; Wojcieszek P; Szlag M; Stankiewicz M; Cholewka A; Ślęczka M; Badora-Rybicka A; Lelek P; Pruefer A; Krzysztofiak T; Kołosza Z; Fijałkowski M
J Contemp Brachytherapy; 2022 Feb; 14(1):43-51. PubMed ID: 35233234
[TBL] [Abstract][Full Text] [Related]
7. Identification of a low risk population for parametrial invasion in patients with early-stage cervical cancer.
Dabi Y; Willecocq C; Ballester M; Carcopino X; Bendifallah S; Ouldamer L; Lavoue V; Canlorbe G; Raimond E; Coutant C; Graesslin O; Collinet P; Bricou A; Huchon C; Daraï E; Haddad B; Touboul C;
J Transl Med; 2018 Jun; 16(1):163. PubMed ID: 29898732
[TBL] [Abstract][Full Text] [Related]
8. Pathologic complete remission after preoperative high-dose-rate brachytherapy in patients with operable cervical cancer: preliminary results of a prospective randomized multicenter study.
Vízkeleti J; Vereczkey I; Fröhlich G; Varga S; Horváth K; Pulay T; Pete I; Nemeskéri C; Mayer Á; Sipos N; Kásler M; Polgár C
Pathol Oncol Res; 2015 Apr; 21(2):247-56. PubMed ID: 25011515
[TBL] [Abstract][Full Text] [Related]
9. Dose gradient impact on equivalent dose at 2 Gy for high dose rate interstitial brachytherapy.
Hannoun-Levi JM; Chand-Fouche ME; Dejean C; Courdi A
J Contemp Brachytherapy; 2012 Mar; 4(1):14-20. PubMed ID: 23346135
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of cancers limited to the uterine cervix with simple hysterectomy using a vaginal approach after brachytherapy].
Resbeut M; Cravello L; Hannoun-Lévi JM; Agostini A; Alzieu C; Cowen D
Cancer Radiother; 1998; 2(3):266-71. PubMed ID: 9749125
[TBL] [Abstract][Full Text] [Related]
11. Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix.
Kim JS; Kim JS; Kim SY; Kim Ki; Cho MJ
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1247-53. PubMed ID: 12654434
[TBL] [Abstract][Full Text] [Related]
12. Combined brachytherapy and surgery for early carcinoma of the uterine cervix: analysis of extent of surgery on outcome.
Resbeut MR; Alzieu C; Gonzague-Casabianca L; Badinand D; Bardou VJ; Cravello L; Gamerre M; Houvenaeghel G; Cowen D
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):873-81. PubMed ID: 11429214
[TBL] [Abstract][Full Text] [Related]
13. [Operable stage IB and II cancer of the uterine neck: retrospective comparison between preoperative utero-vaginal curietherapy and initial surgery followed by radiotherapy].
Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Ganansia V; Bernard A; Antoine JM; Jannet D; Lhuillier PE; Uzan M; Genestie C; Antoine M; Jamali M; Milliez J; Uzan S; Blondon J
Cancer Radiother; 2002 Jun; 6(4):217-37. PubMed ID: 12224488
[TBL] [Abstract][Full Text] [Related]
14. Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy.
Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Antoine JM; Jannet D; Lhuillier P; Uzan M; Huart J; Genestie C; Antoine M; Jamali M; Ganansia V; Milliez J; Uzan S; Blondon J
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):780-93. PubMed ID: 12377330
[TBL] [Abstract][Full Text] [Related]
15. Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgery.
Grigsby PW; Perez CA; Chao KS; Elbendary A; Herzog TJ; Rader JS; Mutch DG
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):645-51. PubMed ID: 10524418
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
